Cafepharma Today

May 15 2025 - FDA approves Amneal's self-administered migraine treatment
FDA approves Amneal's self-administered migraine treatment
VC firm reveals plan for 30K-square-foot biotech incubator space in New Jersey
Philips taps Nvidia to build AI model for MRI
FDA delays decision on Biohaven's rare disease drug filing, plans adcomm
*please scroll down for all the latest news *

Make it like cafepharma, but for different industries. Learn more about CompanyUnderground

Check open job listings in your area
Click here to stay updated on CP happenings

learn about pharmaceutical fraud
learn about the False Claims Act
learn about clinical lab fraud

Current News

submit a press release

Free Speech, Fraud And Clinical Trial Statistics
Pharmalot
Monday, November 7, 2011 - 12:02pm
tags:
clinical trials, fraud, free speech, Medicare, Medicaid, InterMune
Biotechs And Their Trials By Fire
Seeking Alpha
Monday, November 7, 2011 - 11:57am
tags:
MannKind, Keryx, Dendreon, Arena, Biocryst, Aeterna Zentaris, Advanced Cell Technologies
Amgen jumps 5% on $5 billion stock buy-back
Marketwatch
Monday, November 7, 2011 - 11:55am
tags:
Amgen, stock buyback
Cubist begins tender offer for Adolor
Bizjournals.com
Monday, November 7, 2011 - 11:55am
tags:
Cubist, Adolor, M&A
Inhibitex's Future Looks Promising
Seeking Alpha
Monday, November 7, 2011 - 11:09am
tags:
Inhibitex, INX-189, Aurexis, FV100
NPS wraps another positive PhIII study as parathyroid drug impresses
Fierce Biotech
Monday, November 7, 2011 - 11:07am
tags:
NPS Pharmaceuticals, hypoparathyroidism, NPSP558
Pharmasset Rises After Hepatitis Drug Shows 100% Cure Rate
Bloomberg
Monday, November 7, 2011 - 11:02am
tags:
Pharmasset, hepatitis C, PSI-7977
Has Pfizer Become the Perfect Stock?
Motley Fool
Monday, November 7, 2011 - 11:01am
tags:
Pfizer
Ethicon Endo-Surgery completes SterilMed buy
Bizjournals.com
Monday, November 7, 2011 - 11:00am
tags:
M&A, Ethicon-Endo Surgery, SterilMed
Ariad Pharma: Early Efficacy, Safety of Leukemia Drug 'Striking'
TheStreet.com
Monday, November 7, 2011 - 11:00am
tags:
leukemia, Ariad Pharmaceuticals, Ponatinib
GlaxoSmithKline starts search for new directors
Telegraph, UK
Monday, November 7, 2011 - 9:28am
tags:
GSK, pharma execs
Lilly Wins First Trial Over Zyprexa Marketing
Pharmalot
Monday, November 7, 2011 - 9:27am
tags:
antipsychotics, Eli Lilly, Zyprexa
Dendreon, Merck's Hepatitis C Drug: Future Prospects Look Encouraging
Seeking Alpha
Monday, November 7, 2011 - 9:25am
tags:
Merck, Dendreon, hepatitis C, Victrelis
Bayer Shares Rise 4% After Xarelto Wins U.S. FDA Approval
Bloomberg
Monday, November 7, 2011 - 9:24am
tags:
FDA, Bayer, Xarelto, bloodthinners
Sanofi Set To Pass Pfizer As Biggest Drug Company
Seeking Alpha
Sunday, November 6, 2011 - 1:25pm
tags:
Sanofi, Pfizer
Pfizer's, Teva's Results Point To Shifting Demand
Seeking Alpha
Sunday, November 6, 2011 - 12:46pm
tags:
Pfizer, Teva Pharmaceuticals
Abbott Announces New Long-Term Data Evaluating Use of HUMIRA® (Adalimumab) for Patients with Long-Standing Moderate to Severe Rheumatoid Arthritis and for Patients with Early Moderate to Severe RA
Yahoo/PR NewsWire
Sunday, November 6, 2011 - 12:45pm
tags:
Abbott Laboratories, Humira, rheumatoid arthritis
China Biotech Week In Review: Roche's China Strategy
Seeking Alpha
Sunday, November 6, 2011 - 12:43pm
tags:
Roche, China National Biotechnology Group, Aslan, Alios BioPharma, ImmunoBiology Ltd, Healthgen Biotechnology
Investors sue KV Pharmaceutical, alleging misleading statements
STL Today, MO
Sunday, November 6, 2011 - 12:39pm
tags:
KV Pharmaceutical, lawsuits
Biogen-Idec's BG-12 Shines At the Top of the Charts in the Treatment of Relapsing-Remitting Multiple Sclerosis
Bradenton Herald, FL
Sunday, November 6, 2011 - 12:28pm
tags:
Biogen, BG-12, multiple sclerosis, Teva Pharmaceuticals, Copaxone, CONFIRM

Pages

Latest CP Wire Articles

Hermes Intelligence Launches to Redefine Pharma Data Solutions [sponsored]
The Evolution of Medical Sales: What’s Changing in 2025?
FDA Scraps Key Vaccine Meetings—What It Means for Manufacturers
FDA approves Danziten, the first nilotinib treatment for Ph+ CML with no mealtime restrictions
Daily U.S. Flu Cases Expected to Nearly Double from Last Year by Late November, Predicts Novel Mathematical Forecasting Tool
PharmaBlock Receives 2024 ACS CMO Excellence in Green Chemistry Award, Marking a Second Consecutive Year of Recognition
Leading Clinical Research Network Centricity Research Acquires North Carolina-based Lucas Research
First-of-Its-Kind Alzheimer’s Disease Simulation Paves Way for Personalized Treatment: Penn State, Duke University Study
Centricity Research Appoints New CEO, CFO to Support Next Phase of Growth
Sermo Barometer Examines Influencers’ Impact on Patient Perceptions of Weight Loss Medications & Preventative Care Technologies

Latest Pharmagather Articles

Obesity Without Metabolic Dysfunction?
In the Pipeline
New Cell Therapy For Resistant Hodgkins Patients
In the Pipeline
Escape From the Lysosome
In the Pipeline
Heavy Water in Your NMR Experiments, And Elsewhere
In the Pipeline
GIPR: Agonists and Antagonists Do the Same Thing, But How
In the Pipeline
Mutant Proteins Classified
In the Pipeline
The Continuing Crisis, Part XIV: The Trumpist Worldview
In the Pipeline
Whole Lotta Snakin' Going On
In the Pipeline
The GLP-1 Saga Continues, And How
In the Pipeline

current feelings about your job

Please rate how you feel about your job this moment. 1 = "I hate my job" and 7 = "I love my job"
CAPTCHA
This question is for testing whether or not you are a human visitor and to prevent automated spam submissions.
Fill in the blank.